RxDoctor Payments Data

Luke Mueller, MD

Family Medicine · Lawrence, KSNPI 1578945713

Payments from drug & device makers

$754in general payments, 2019–2025

Across 37 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$141
  • Novo Nordisk$126
  • Teva Pharmaceuticals USA, Inc.$117
  • Otsuka America Pharmaceutical, Inc.$83
  • AbbVie$71
  • Lilly USA, LLC$41
  • plus $175 from 8 others

What the payments were for

  • Food & beverage$754100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$754 in reported general payments places this provider in the 55th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$932
Medicare patients
42
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide75$121,135
EliquisApixaban71$73,000
Trelegy ElliptaFluticasone/Umeclidin/Vilanter62$51,189
JardianceEmpagliflozin53$48,010
JanuviaSitagliptin Phosphate35$27,378
MounjaroTirzepatide16$16,076
LinzessLinaclotide18$13,433
Spiriva HandihalerTiotropium Bromide11$8,868
Tresiba Flextouch U-100Insulin Degludec11$8,302
Advair HfaFluticasone Propion/Salmeterol17$7,864
Incruse ElliptaUmeclidinium Bromide15$6,587
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl40$6,564
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$5,397
Fluticasone-SalmeterolFluticasone Propion/Salmeterol37$4,965
Novolog FlexpenInsulin Aspart17$3,571

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$126$121,13575 claims
MerckJanuvia$24$27,37835 claims
Lilly USA, LLCMounjaro$41$16,07616 claims
AbbVieLinzess$71$13,43318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Lawrence

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →